Roxanne Wood - Oncology Research Group, Brown University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Final Results of BrUOG 354: A Randomized Phase II Trial of Nivolumab Alone or in Combination with Ipilimumab for People with Ovarian and Other Extra-Renal Clear Cell Carcinomas

Don S. Dizon,Cara Amanda Mathews,Shannon MacLaughlan David,Jason T. Machan,Matthew James Hadfield,Eric Marks,Rani Bansal,Christine McGinn, Faith Hassinger,Denise Luppe, Janine Grigelevich, Kelly A. Mitchell, Adam Braga,Ashlee Sturtevant,Roxanne Wood,Ursula A. Matulonis,Alexi A. Wright,Susana M. Campos,Michael J. Birrer

JOURNAL OF CLINICAL ONCOLOGYno. 17_SUPPL (2024): LBA5500-LBA5500

引用0浏览0引用

NeoRad(Low): A Phase 2 Trial of Neoadjuvant (NA) Ipilimumab Plus Nivolumab (ipi Plus Nivo) with Low Dose Stereotactic Body Radiation Therapy (SBRT) As an Immune Stimulant in Patients with Resectable Stage IB-III Non-Small Cell Lung Cancer (NSCLC)

Thomas A. DiPetrillo, Maria Garcia-Moliner, Paul Koffer, Jaroslaw T. Hepel, Hina Khan,Humera Khurshid, Abbas, Ariel E. Birnbaum, Adam J. Olszewski, Cheyenne Ferreira, Faith Hassinger, Michele Carlin McCormick, Hannah Giesing, Nuno Rodrigues, Vallerie Rosati,Roxanne Wood, Amy Webber, Sara Maleki, Christopher G. Azzoli

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Durvalumab and Consolidation SBRT Following Chemoradiation for Stage III Non-Small Cell Lung Cancer: A Single Institution Pilot Study